MED7 Antilichaam / Middelaar van RNA polymerase II transcriptie subeenheid 7

MED7 is ubiquitously expressed and contributes to the regulation of genes involved in development, cell cycle progression, and differentiation. Dysregulation of Mediator subunits, including MED7, has been linked to transcriptional misregulation in cancer and developmental disorders, making it an important target in transcriptional biology research. Using a high-quality MED7 antibody allows sensitive detection in applications such as western blot, immunohistochemistry, and chromatin immunoprecipitation. A MED7 antibody from NSJ Bioreagents ensures specificity and reproducibility for studies focused on transcriptional control, Mediator complex biology, and disease mechanisms. Selecting the right MED7 antibody is essential for generating consistent and meaningful data.

Western blot: 0.5-1 µg/mL, Immunofluorescence: 5 µg/mL, Immunoprecipitation: 2ug per 500ug of lysate

O43513

Human, Mouse, Rat

Recombinant human protein (amino acids M1-P233) was used as the immunogen for the MED7 antibody.

WB, IF, IP

Antigen affinity purified

Antigen affinity purified

Lyophilized from 1X PBS with 2% Trehalose

This MED7 antibody is available for research use only.

After reconstitution, the MED7 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.

0.5 mg/mL if reconstituted with 0.2ml sterile DI water

Optimal dilution of the MED7 antibody should be determined by the researcher.

Nucleolus

Immunofluorescent staining of FFPE human A549 cells with MED7 antibody (red) and Beta Tubulin mAb (green) . HIER: steam section in pH6 citrate buffer for 20 min.